Skip to Content
Corporate Sponsorships
Member Login
Search
Member Login
Give
Corporate Sponsorship
SEARCH
About Us
About ASTCT
Board of Directors
President Message
Partner Organizations
For Media
Contact ASTCT
Committees
Membership
Volunteer With ASTCT
Become a Member
Member Spotlights
Member Directory
Special Interest Groups
Community Forum
Mentor Match
Education
Practice Guidelines
Learning Center
Patient Education
Coverage, Coding, Billing
CAR-T Therapy Coding and Billing Guide
HCT Coding and Billing Resources
Payer RFI Forms
Meetings
Meetings
Meetings Calendar
Clinical Research Training Course
Fundamentals of Transplant and Cellular Therapy
Gene Therapy Summit
Publications & Podcasts
Journal: Transplantation and Cellular Therapy
Trending Topics: Nucleus
Podcast: ASTCT Talks
Newsletters
Tandem Meetings News
Careers
Career Center
Fellowship Programs
Fellowship Connections
Grants
Awards
Advocacy
ASTCT Advocacy
Policy Updates
Policy/Payer Letters and Statements
ACCESS Initiative
Hill Day
Trending topics and news in HCT and Cellular Therapy
Topics to Explore
ASTCT NEWS
CAR T
GVHD
TIL
SCIENCE HIGHLIGHTS
MORE TOPICS
BISPECIFICS
MRD
NM Submissions
ASTCT News
Podcast: Is Less More? Antibiotic De-escalation in Hematopoietic Cell Transplants
by ASTCT Talks and Oncology On the Go
In a cobranded episode between Oncology On the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, an expert...
RECENT INSIGHTS
Science Highlights
Evaluating Allo-HCT for Myelodysplastic Syndromes in Young Adults
by Bone Marrow Transplantation
A large registry analysis found that allogeneic hematopoietic cell transplantation (allo-HCT) produced encouraging long-term outcomes in young adults with myelodysplastic syndromes (MDS), with a...
Science Highlights
MRD-Directed Therapy Prior to Autologous Transplantation
by Leukemia & Lymphoma
A retrospective study suggests that MRD-guided treatment intensification before autologous stem cell transplantation can deepen responses in patients with newly diagnosed multiple myeloma. Most...